By framing metabolic reprogramming as a network-level target, this review offers a novel perspective on overcoming the specificity challenges that have hindered the clinical application of immunometabolism research
[DOI] [PubMed] [Google Scholar] 366.Yoshida N., Ikeda Y., Notomi S., Ishikawa K., Murakami Y., Hisatomi T., et al
Research demonstrates that it promotes synapse formation at approximately 10 million times the potency of BDNF itself, working through the hepatocyte growth factor (HGF) and c-Met receptor pathway
Methanol (VWR Chemicals), formic acid (Sigma-Aldrich, West Chester, PA, USA) & DMSO Sigma-Aldrich (West Chester, PA, USA), NADPH (Merk, USA)